Image source: Shutterstock

Highlights

  • Omega Healthcare’s FY24 revenue surged to USD 1,051.4 million, reflecting a 10.7% increase from FY23
  • Net income for FY24 reached USD 406.3 million, marking a 67.8% increase over the previous year
  • Omega Healthcare expects 2025 AFFO per share to range between USD 2.90 and USD 2.98
  • The company plans to repay USD 631 million in debt and expects a year-end cash balance of approximately USD 600 million

 Omega Healthcare Investors, Inc. (NYSE:OHI) is a real estate investment trust (REIT)and it operates through a single segment, which invests in healthcare-related real estate properties located in the US and the UK.

In the financial year 2024 (FY24), the company saw a notable increase in total revenue to USD 1,051.4 million from USD 7.3 million in FY23, reflecting a growth of 10.7%. This surge in revenue was primarily driven by the successful completion of new investments throughout 2023 and 2024. Additionally, the timing and impact of operator restructurings and transitions played a key role in bolstering revenue.

The company also achieved a notable increase in net income in FY24, reaching USD 406.3 million in FY24, up 67.8% from the previous year’s USD 242.2 million. This growth was fueled by the higher revenue and a reduction in total expenses, although it was slightly offset by a decrease in gains from asset sales.

The company also reported an increase in cash inflows from operating activities, which amounted to USD 733.9 million in FY24, marking a 24.1% rise compared to USD 591.2 million in FY23. This growth was attributed to favorable changes in net working capital and the higher net income. Cash and cash equivalents also saw a rise, increasing by 17.1% YoY to USD 518.3 million from USD 442.8 million in FY23. This improvement was driven by cash inflows from both operations and financing activities, although partially offset by outflows from investing activities.

Company Outlook

Omega Healthcare expects its 2025 Adjusted Funds From Operations (AFFO) to be between USD 2.90 and USD 2.98 per diluted share. This projection takes into account acquisitions made in 2024 and early 2025. It also factors in quarterly G&A expenses of USD 12 million to USD 14 million and asset sales of USD 56 million.

The company plans debt repayments of USD 631 million, which includes USD 400 million in senior unsecured debt and a USD 231 million mortgage loan. Additionally, loan receivable repayments are expected to total USD 28 million.

Omega Healthcare also anticipates a year-end cash balance of around USD 600 million, assuming stable interest rates and no new cash-basis operators.

Top 10 Shareholders

The top 10 shareholders of Omega Healthcare collectively own about 47.36% of the company's total shares, indicating a high concentration of ownership. Among these, The Vanguard Group, Inc. holds the largest stake at approximately 13.42%, followed by BlackRock Institutional Trust Company, N.A., with a holding of around 10.19%.

Stock Information

OHI's stock has posted a modest gain of 0.95% over the last three months. Looking at a longer-term trend, the stock has fallen by 5.57% over the past six months. Currently, the stock price is hovering near the midpoint between its 52-week high of USD 44.41 and its 52-week low of USD 29.66. As of March 28, 2025, the stock closed at USD 38.08.

 Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference data for all price data, currency, technical indicators, support, and resistance levels is 28 March 2025. The reference data in this report has been partly sourced from EODHD/Others.

 Technical Indicators Defined

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.